Aardvark Therapeutics, Inc. Common Stock • AARD

Capital at risk.

About Aardvark Therapeutics, Inc. Common Stock
Ticker
info
AARD
Trading on
info
NASDAQ
ISIN
info
-
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Tien-Li Lee M.D.
Headquarters
info
4370 La Jolla Village Drive, San Diego, CA, United States, 92122
Employees
info
17
Website
info
https://aardvarktherapeutics.com
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is the ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen that is in Phase III clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in Phase II clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from treatment of craniopharyngioma, including surgery or radiation. It also developing ARD-201, which is in Phase I clinical trial for the treatment of obesity. The company was incorporated in 2017 and is based in San Diego, California.
Metrics
BasicAdvanced
Market cap
info
$284M
P/E ratio
info
-
EPS
info
-$0.65
Dividend Yield
info
0.00%
Beta
info
-
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$284M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0
Earnings
EPS
info
-$0.65
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
-
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-
52-week High
info
$19.58
52-week Low
info
$10.90
50-day moving average
info
$13.81
200-day moving average
info
$13.81
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
0.00%
ROA (TTM)
info
0.00%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
21.4M
Float
info
18.4M
Insiders %
info
24.03%
Institutions %
info
24.90%
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-2M
∞%
Q4 • 23
$0M
$-4.2M
∞%
Q3 • 24
NaN%
104.90%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$87.2M
$130M
148.51%
Q2 • 24
$83.7M
$130M
155.14%
Q3 • 24
3.97%
0.31%
4.46%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.2M
$0M
$0M
$-1.2M
Q4 • 23
$-4M
$-0M
$0.1M
$-4M
Q3 • 24
242.13%
∞%
∞%
242.56%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Aardvark Therapeutics, Inc. Common Stock share?
Collapse

Aardvark Therapeutics, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does Aardvark Therapeutics, Inc. Common Stock have?
Collapse

Aardvark Therapeutics, Inc. Common Stock currently has 21.4M shares.

Does Aardvark Therapeutics, Inc. Common Stock pay dividends?
Collapse

No, Aardvark Therapeutics, Inc. Common Stock doesn't pay dividends.

What is Aardvark Therapeutics, Inc. Common Stock 52 week high?
Collapse

Aardvark Therapeutics, Inc. Common Stock 52 week high is $19.58.

What is Aardvark Therapeutics, Inc. Common Stock 52 week low?
Collapse

Aardvark Therapeutics, Inc. Common Stock 52 week low is $10.90.

What is the 200-day moving average of Aardvark Therapeutics, Inc. Common Stock?
Collapse

Aardvark Therapeutics, Inc. Common Stock 200-day moving average is $13.81.

Who is Aardvark Therapeutics, Inc. Common Stock CEO?
Collapse

The CEO of Aardvark Therapeutics, Inc. Common Stock is Dr. Tien-Li Lee M.D..

How many employees Aardvark Therapeutics, Inc. Common Stock has?
Collapse

Aardvark Therapeutics, Inc. Common Stock has 17 employees.

What is the market cap of Aardvark Therapeutics, Inc. Common Stock?
Collapse

The market cap of Aardvark Therapeutics, Inc. Common Stock is $284M.

What is the P/E of Aardvark Therapeutics, Inc. Common Stock?
Collapse

The current P/E of Aardvark Therapeutics, Inc. Common Stock is null.

What is the EPS of Aardvark Therapeutics, Inc. Common Stock?
Collapse

The EPS of Aardvark Therapeutics, Inc. Common Stock is -$0.65.

What is the PEG Ratio of Aardvark Therapeutics, Inc. Common Stock?
Collapse

The PEG Ratio of Aardvark Therapeutics, Inc. Common Stock is null.